Latest Experimental cancer treatments Stories

2014-01-08 12:28:55

SYDNEY, Jan. 8, 2014 /PRNewswire/ -- Viralytics Limited (ASX: VLA, OTCQX: VRACY) can report that the 54(th) late stage melanoma patient has been injected with CAVATAK(TM), thus achieving the major milestone of target enrolment in the US Phase 2 CALM trial. The Phase 2 trial is a single arm study being conducted at 11 US cancer clinics to investigate the safety and efficacy of intratumoral CAVATAK(TM) (Coxsackievirus A21) in patients with late stage malignant melanoma. Dr. Malcolm...

2014-01-06 08:27:53

WORCESTER, Mass. and TORONTO, Jan. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced the database lock for the primary efficacy analysis of its ongoing AE37 breast cancer vaccine trial. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). A previously released positive interim analysis showed a strong trend toward reduced...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.